期刊文献+

血清1,3-β-D葡聚糖和半乳甘露聚糖抗原联合检测对血液肿瘤患者侵袭性真菌感染的早期诊断价值 被引量:5

Value of serum galactomannan enzyme immunoassay combine with 1,3 beta-glucan assay for diagnosis of invasive fungal infection in hematological disorders
暂未订购
导出
摘要 目的:评价血清1,3-β-D葡聚糖(G)和半乳甘露聚糖(GM)抗原联合检测对血液肿瘤患者侵袭性真菌感染(IFI)的早期诊断价值。方法:42例中性粒细胞减少伴发热,经广谱抗生素治疗无效的血液病患者,根据临床回顾性诊断标准定义阳性和阴性病例。采用ELISA试剂盒检测患者血清G和GM,分别计算GM试验和G试验及联合检测的灵敏度、特异度、阳性和阴性预测值。结果:以I值>1.0为GM试验阳性,G浓度>60 pg/L为G试验阳性计算,GM试验和G试验联合检测的灵敏度、特异度、阳性和阴性预测值77.8%,90.3%,82.4%,87.5%;G试验的灵敏度和阳性预测值高,但GM试验的特异度高。结论:GM试验和G试验联合检测提高试验的敏感度,减少了假阴性的发生,对早期诊断IFI有一定的临床意义。 Objective:To evaluate the value of serum galactomannan (GM) enzyme immunoassay combine with 1, 3 beta-glucan (G) assay for diagnosis of invasive fungal infection (IFI) in hematological disorders. Method.. Blood samples were obtained from 42 patients with neutropenic hematological disorder, fever and shown no response to broad-spectrum antibiotics therapy. Serum concentration of GM and G were detected by enzyme linked immunosorbent assay. The proven IFI and non-IFI patients were defined by retrospective clinical analysis according to domestic IFI diagnostic criteria. Result:GM positive was defined as I index〉1. 0 and G positive was defined as G〉60 ng/L, The sensitivity an specificity of both GM and G assay were 77.8% and 90.3% and the positive and negative predictive values were 82.4% and 87.5% respectively. The performance of G-based diagnosis appears to be better for sensitivity. GM assay was shown to have a higher specificity than BG assay. Conclusion..Serum GM enzyme immunoassay combine with 1, 3 beta-glucan (G) assay for diagnosis of IFI in hematological disorders increased sensitivity of detecting IFI and decreased false negative cases, and it could be a more reliable method for early diagnosis of IFI.
出处 《临床血液学杂志》 CAS 2009年第3期253-255,共3页 Journal of Clinical Hematology
基金 深圳市科技局项目资助(No:200703211)
关键词 真菌感染 葡聚糖类 半乳甘露聚糖 诊断 fungal infection glucans galactomannan diagnosis
  • 相关文献

参考文献5

二级参考文献25

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:424
  • 2朱小敏,周新.侵袭性肺曲霉病的诊断与治疗[J].中国呼吸与危重监护杂志,2005,4(4):316-320. 被引量:36
  • 3Marr KA,Carter RA,Boeckh M,et al.Invasive aspergillosis in allogeneic stem cell transplant recipients:changes in epidemiology and risk factors.Blood,2002,100:4358-4366.
  • 4Singh N,Paterson DL.Aspergillus infections in transplant recipients.Clin Microbiol Rev,2005,18:44-69.
  • 5Mennink-Kersten MA,Donnelly JP,Verweij PE.Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.Lancet Infect Dis,2004,4:349-357.
  • 6Marr KA,Balajee SA,McLaughlin L,et al.Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis:variables that affect performance.J Infect Dis,2004,190:641-649.
  • 7Maertens J,Theunissen K,Verbeken E,et al.Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.Br J Haematol,2004,126:852-860.
  • 8Walsh LTJ,Shoham S,Petraitiene R,et al.Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro,in vivo,and clinical properties of the drugantigen interaction.J Clin Microbiol,2004,42:4744-4748.
  • 9Mattei D,Rapezzi D,Mordini N,et al.False-positive aspergillus galactomannan enzyme-linked immunosorbent saasy results in vivo during amoxicillin-clavulanic acid treatment.J Clin Microbiol,2004,11:5362-5363.
  • 10Maschmeyer G.The changing epidemiology of invasive fungal infections:new threats.Int J Antimicrob Agents,2006,27 Suppl 1:3-6.

共引文献481

同被引文献91

引证文献5

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部